Three Picks From the Ultimate Stock Pickers' New Purchases
Combining our managers' recent activity with our ratings uncovers some ideas.
By Brett Horn | Associate Director
We often like to take a look at what our Ultimate Stock-Pickers are buying for the first time within their portfolios, also known as new money purchases. Combing through the current holdings of our Ultimate Stock-Pickers gives only a limited indication of what stocks these managers believe are currently worth buying, as some of these holdings may have been bought a while back, when prices were at a different level. Looking at new money purchases give us some insight into what these stock pickers think are the most attractive buying opportunities right now. However, since these funds report their new positions with a lag, the prices they paid for these stocks could differ significantly from their prices today. Still, new money purchases are a better indication of potential opportunities than just looking a manager's overall holdings, in our opinion.
As we farmed through the list of the top 25 new money purchases for the most recent period, we paid particular attention to a few main factors. First, only two stocks were purchased by multiple fund managers. A new position purchased by multiple funds indicates that more than one manager views the particular stock as a great buying opportunity. The two stocks we found that met this criterion were Bank of America (BAC), which was purchased by Fairholme (FAIRX) and Sound Shore (SSHFX), and Teva Pharmaceutical (TEVA), which was purchased by Markel Corporation (MKL) and Oak Value (OAKVX).
The Morningstar Ultimate Stock-Pickers Team does not own shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
We’d like to share more about how we work and what drives our day-to-day business.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
To learn more about how we handle and protect your data, visit our privacy center.
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.
To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.
Read our editorial policy to learn more about our process.